For Obese Type-2 Diabetes Patients Associated with
Increased Risk of Insulin Resistance & CVD
Glimepiride 1 & 2 mg + Metformin (SR) 500 mg + Pioglitazone 15 mg Tablets
The Time Tested Combination
- The PROactive with 5.238 patients with T-2 DM and pre-existing CVD: Pioglitazone is known to improve insulin sensitivity, glycemic control, dyslipidemia, hypertension, and microalbuminuria
- Improving the sensitivity of heptic and peripheral (muscle) tissue to insulin
- Increase HDL cholestrol, decrease fasting triglycerides, and increases fasting plasma free fatty acids
